Science Current Events | Science News | Brightsurf.com
 

Lack of a key enzyme dramatically increases resistance to sepsis

April 24, 2006
Findings could lead to new therapeutic approaches to a major disease

According to the new study, the presence of caspase-12, which appears to modulate inflammation and innate immunity in humans, increases the body's "vulnerability to bacterial infection and septic shock" while a deficiency confers strong resistance to sepsis. This new discovery suggests that caspase-12 antagonists could be a potentially useful in the treatment of sepsis and other inflammatory and immune disorders.

The study was published in the April 20 edition of the journal Nature (Volume 440, Number 7087).

Richard Ulevitch, chair of the Scripps Research Immunology Department and an author of the paper, says, "The results of the study make clear that caspase-12 plays a critical role in the elimination of bacterial pathogens, and that a deficiency allows systemic and abdominal infections to be better resolved. It's known that the presence of caspase-12 as a full length protein occurs in a small percentage of people of African descent. As a result, some of these individuals are far more susceptible to severe sepsis and have a significantly increased risk of dying from it."

Sepsis, the body's inflammatory response to severe infection, is one of the leading causes of death in the United States, killing more than 200,000 people each year, according to the Society of Critical Care Medicine. A 2003 study by The Centers for Disease Control and Emory University School of Medicine showed that the incidence of sepsis in the United States has increased almost nine percent a year since 1979.

The new study showed that caspase-12 deficient mice were resistant to peritonitis and septic shock and were able to clear pathogenic bacteria more efficiently than mice with the enzyme. The presence of caspase-12 also reduced production of several pro-inflammatory cytokines, increasing vulnerability to bacterial infection and septic mortality.

"Without the experimental model of peritonitis perfected by John Mathison from Scripps Research, we would not have been able to differentiate between the two mouse phenotypes," Ulevitch said. "Because of his work, we were able to use a surgically implanted stent in the colon that allowed a gradual occurrence of sepsis and easy identification."

A majority of mice with caspace-12 died from sepsis within the first 48 hours after onset, while 60 percent of the caspase-12 deficient mice survived. The deficient mice also showed a significantly lower number of bacterial colony-forming units per milliliter of blood, suggesting that more efficient bacterial clearance occurs in the absence of caspase-12.

Caspase-12 is also an inhibitor of caspase-1, a related enzyme involved in the inflammation process. Caspase-1 deficient mice are two-to-three times more susceptible to lethal Escherichia coli infection than normal mice. Consequently, the study said, sepsis resistance in caspase-12 deficient mice was most likely due to an initial hyper-production of cytokines that fight the infection.

"The resulting beneficial effect of cytokine hyper-production runs contrary to some of the current thinking in sepsis research," Ulevitch said. "The general thinking is that this initial cytokine 'storm' is harmful, and that belief has been the basis of a number of unsuccessful clinical studies. In our study, cells containing caspase-12 appear to weaken the activity of caspase-1 that is normally essential for bacterial clearance and sepsis survival."

In another finding, researchers showed that both mouse models had similar levels of stress-induced apoptosis or programmed cell death. While caspase-12 was previously thought to be a key mediator of endoplasmic reticulum apoptosis, the new study found that the presence or absence of caspase-12 had no effect on apoptotic sensitivity whatsoever.

Others authors of the study include Maya Saleh (currently with McGill University), Melissa K. Wolinski, Steve J. Bensinger, Patrick Fitzgerald, Nathalie Droin, Douglas R. Green (La Jolla Institute of Allergy and Immunology and St. Jude Children's Research Hospital); Donald W. Nicholson of Merck Research Laboratories, and; John C. Mathison of Scripps Research.

Scripps Research Institute


Related Sepsis Current Events and Sepsis News Articles


World's first bilateral hand transplant on child at Children's Hospital of Philadelphia
Surgeons at The Children's Hospital of Philadelphia (CHOP) joined with colleagues from Penn Medicine recently to complete the world's first bilateral hand transplant on a child.

Extreme exercise linked to blood poisoning
Researchers have discovered that extreme exercise can cause intestinal bacteria to leak into the bloodstream, leading to blood poisoning.

New microscope technique could speed identification of deadly bacteria
A new way of rapidly identifying bacteria, which requires a slight modification to a simple microscope, may change the way doctors approach treatment for patients who develop potentially deadly infections and may also help the food industry screen against contamination with harmful pathogens, according to researchers at the Korea Advanced Institute of Science and Technology (KAIST) in Daejeon, South Korea.

Scientists discover bacterial cause behind fatal heart complications
Streptococcus pneumoniae is a major human pathogen and is known to be associated with increased risk of fatal heart complications including heart failure and heart attacks.

Single low-magnitude electric pulse successfully fights inflammation
The Feinstein Institute for Medical Research, the research arm of the North Shore-LIJ Health System, and SetPoint Medical Inc., a biomedical technology company, today released the results of research on the therapeutic potential of vagus nerve stimulation.

Stanford scientists find genetic signature enabling early, accurate sepsis diagnosis
Investigators at the Stanford University School of Medicine have identified a pattern of gene activity that could help scientists create a blood test for quickly and accurately detecting whether patients are experiencing a deadly immune-system panic attack.

In late post-surgical colon 'leaks,' finger points to microbes
Post-surgical leaks that develop after a segment of the colon has been removed and stitched back together often are caused not by negligence or technical error but by bacteria in the bowel that elude antibiotics, according to new evidence about this devastating complication of gastrointestinal surgery.

New care approach to colorectal operations speeds patients' recovery times
Patients undergoing colorectal operations who participated in an enhanced recovery program left the hospital sooner and had significantly lower hospital costs than patients who had the traditional approach to their care, according to a new study, which also found further postoperative improvements after adding an infection prevention protocol.

Cirrhosis deaths drop 41 percent from 2002 to 2012
A new study by UNC researchers has found dramatic improvements in the survival of patients with cirrhosis and liver failure supporting improved treatment strategies for patients with cirrhosis and concurrent bacterial infections.

Study examines long-term adverse health effects of Ebola survivors
Ebola survivors experienced negative health effects that persisted more than two years after the 2007-2008 Bundibugyo ebolavirus (BDBV) outbreak in Uganda that claimed 39 lives.
More Sepsis Current Events and Sepsis News Articles

Sepsis: Diagnosis and Treatment

Sepsis: Diagnosis and Treatment
by NetCE


The purpose of this course is to provide healthcare professionals with evidence-based recommendations so they may optimally manage the patient who presents with sepsis and septic shock and minimize adverse outcomes. In addition, members of the public may use this course to enhance their personal knowledge of the subject matter presented.

Upon completion of this course, you should be able to:

1. Define the various degrees of sepsis, and describe the history and incidence of sepsis relative to mortality.
2. List the risk factors associated with the development of sepsis.
3. Describe the pathogenesis of SIRS, including the five phases of development, and the pathophysiology of sepsis.
4. List potential organ manifestations related to the...

Sepsis: Diagnosis, Management and Health Outcomes (Allergies and Infectious Diseases)

Sepsis: Diagnosis, Management and Health Outcomes (Allergies and Infectious Diseases)
by Nancy, M.D., Ph.D. Khardori (Editor)




My Sepsis Story: How I Almost Died and You Don't Have To

My Sepsis Story: How I Almost Died and You Don't Have To
by Lisa Brandt Creative Services


I am not a doctor. But when everyone, including a doctor, said I had the flu, I knew it was something more. I'm a survivor of sepsis. Chances are, you aren't familiar with sepis, but it kills more people than cancer and is more common than heart attack. And I want you to know about it so you can avoid what I went through. My story is anything but a Debbie Downer tale. After all, you already know it has a happy ending.

Sepsis and Septic Shock

Sepsis and Septic Shock


Sepsis and Septic Shock

Last updated: 9/30/12, 5/21/13
Number of questions: 12

ABC of Sepsis

ABC of Sepsis
by Ron Daniels (Editor), Tim Nutbeam (Editor)


The importance of early prevention and treatment of sepsis has never been greater. In the UK alone sepsis contributes to more deaths than lung cancer, from bowel cancer and breast cancer combined, and approximately one third of patients who suffer from severe sepsis die. The ABC of Sepsis provides a much needed introduction and an invaluable aid in the increasing efforts to reduce hospital infection and improve patient safety. As growing numbers of junior medical staff experience emergency medicine, critical care and acute medicine as part of the Foundation Programme, there is an increasing need to develop the skills required to treat severe sepsis. The editors are involved with the Survive Sepsis campaign - developed to improve the recognition, diagnosis and treatment of sepsis - and...

SEPSIS Handbook: Early Diagnosis of SEPSIS

SEPSIS Handbook: Early Diagnosis of SEPSIS
by Phil Dellinger and Jean Carlet (Editor)




Gyroscope- A Survival of Sepsis

Gyroscope- A Survival of Sepsis
by Gary Black (Author)


Gyroscope is a compelling and inspiring true story about a miraculous survival of sepsis. It reveals and illustrates the innermost traumas and triumphs of a journey through this devastating illness.

Actual book size is 6 x 9

Sepsis: Chapter 172 of Emergency Medicine

Sepsis: Chapter 172 of Emergency Medicine
by Saunders


Chapter 172, Sepsis, from Emergency Medicine, 2nd Edition delivers all the relevant clinical core concepts you need for practice and certification, all in a comprehensive, easy-to-absorb, and highly visual format. This well-regarded emergency medicine reference offers fast-access diagnosis and treatment guidelines that quickly provide the pearls and secrets of your field, helping you optimize safety, efficiency, and quality in the ED as well as study for the boards.

The Sepsis Text

The Sepsis Text
by Jean-Louis Vincent (Editor), Jean Carlet (Editor), Steven M. Opal (Editor)


This textbook is written at the dawn of a new era in the management of sepsis. Recent achievements in the clinical management of septic shock are the culmination of decades of basic and applied research by innovative researchers and clinical investigators worldwide. The contributing authors to this book have spearheaded much of this research and the Editors have endeavored to create a textbook that is comprehensive in nature while maintaining a specific focus upon the multitude of work that constitutes the spectrum of sepsis research including: pathophysiology; monitoring systems; general support; microbial aspects; complications; and anti-sepsis therapies.

Sepsis Management: PIRO and MODS

Sepsis Management: PIRO and MODS
by Jordi Rello (Editor), Jeffrey Lipman (Editor), Thiago Lisboa (Editor)


This book is unique in approaching multiple organ dysfunction syndrome (MODS) from the perspective of its pathophysiological mechanism, and addressing aspects that are overlooked in most of the available literature. Eminent experts in the field from Europe and beyond offer new insights into risk stratification, severity assessment, and management of critically ill patients with sepsis. The principal focus is on recently developed concepts in infection management and in antibiotic use, bearing in mind that in these patients the pharmacokinetics of antibiotics are altered, affecting renal clearance and requiring dosage adjustments. The significance of the PIRO (predisposing factors, infection, response, organ dysfunction) model in the development of effective treatment strategies is...

© 2015 BrightSurf.com